SANGAMO THERAPEUTICS, INC. Income Taxes Receivable, Current
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Income Taxes Receivable, Current of $5.49 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2026-05-14
- 2026-03-31: Income Taxes Receivable, Current $5.49M.
- 2025-12-31: Income Taxes Receivable, Current $10.14M.
- 2025-09-30: Income Taxes Receivable, Current $4.60M.
- 2025-06-30: Income Taxes Receivable, Current $4.60M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2026-03-31 | $5.49M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $10.14M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $4.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.60M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.24M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $4.07M 10-K · filed 2026-03-30 |
| 2023-12-31 | $3.14M 10-K · filed 2025-03-17 |